Cargando…
Targeting Cyclic AMP Signalling in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a major healthcare problem worldwide, representing one of the leading causes of cancer mortality. Since there are currently no predictive biomarkers for early stage diagnosis, HCC is detected only in advanced stages and most patients die within one year, as radical...
Autores principales: | Massimi, Mara, Ragusa, Federica, Cardarelli, Silvia, Giorgi, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952960/ https://www.ncbi.nlm.nih.gov/pubmed/31775395 http://dx.doi.org/10.3390/cells8121511 |
Ejemplares similares
-
Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma
por: Ragusa, Federica, et al.
Publicado: (2021) -
Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
por: Giorgi, Mauro, et al.
Publicado: (2020) -
Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms
por: Cardarelli, Silvia, et al.
Publicado: (2022) -
The Role of Cyclic AMP Signaling in Cardiac Fibrosis
por: Delaunay, Marion, et al.
Publicado: (2019) -
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?
por: Baiocchi, Leonardo, et al.
Publicado: (2021)